Table 2.
Healthcare utilization among individuals age 15–64 years diagnosed with schizophrenic disorders: 2008–2015
| Healthcare utilization | N | Median (IQR) |
| Overall outpatient visits | 799,290 | 4.5 (2.0–8.2) |
| Outpatient visits (SD) | 666,347 | 3.8 (1.5–7.0) |
| a Specialist visits | 312,520 | 0.96 (0.0–3.6) |
| b Length of hospital stay (days) | 286,139 | 4.0 (1.6–9.2) |
| c Work absences (days) | 292,780 | 12.5 (3.4–28.8) |
| Antipsychotics dispensations | 2,861,262 | 15.1 (6.6–28.5) |
| Antipsychotics dispensations families | N (%) | d Subjects treated (%) |
| OA-2nd generation | 1,696,420 (59.3) | 93.4 |
| LAI-2nd generation | 576,913 (20.2) | 36.0 |
| OA-1st generation | 409,121 (14.3) | 33.8 |
| LAI-1st generation | 106,103 (3.7) | 14.7 |
| Other | 72,705 (2.5) | 13.3 |
Abbreviations: IQR Interquartile ratio, LAI Long-acting injection antipsychotics, OA Oral antipsychotic
Median is presented as a rate in person-year
a Corresponding to mental health specialist visits with the ICD-9-CM code 295.XX
b Corresponding to 21,095 hospitalizations in the cohort of patients with SD
c Corresponding to 5445 work absences in the cohort of patients with SD
d Subjects treated with antipsychotic drugs at some point during the study period